Frontmasta
16.11.2017 kl 23:38
1817

Lisa Rojkjaer, Chief Medical Officer of Nordic Nanovector, commented: "These
data are very encouraging for a primarily elderly, heavily pre-treated patient
population,

Elderly er vel de over 65 år......
Arkivert